In the spline regression analyses between CSF neurodegeneration and amyloidosis biomarkers and CSF selenoprotein P levels, Aβ1-42 levels slightly and positively correlated with selenoprotein P in the AD group. The gene discussed is SELENOP; the disease is Alzheimer disease.